Anondita Medi Stock Price Today (NSE: ANONDITA)
Fundamental Score
Anondita Medi Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Anondita Medi share price today is ₹1097.60, up +8.32% on NSE/BSE as of 22 June 2026. Anondita Medi (ANONDITA) is a Small-cap company in the Personal Care sector with a market capitalisation of ₹1.19K (Cr). The 52-week high for ANONDITA share price is ₹1190.00 and the 52-week low is ₹416.05. At a P/E ratio of 51.90x, ANONDITA is currently trading above its industry average P/E of 50.39x.
Anondita Medi Share Price Chart — NSE/BSE Historical Performance
Anondita Medi share price chart: -12.35% return over the past month. 52-week high ₹1190.00, 52-week low ₹416.05.
Anondita Medi — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1042.80 | ₹1100.00 | ₹1042.80 | ₹1097.60 | 18.00K (Cr) | |
| ₹1045.35 | ₹1050.00 | ₹995.05 | ₹1013.25 | 14.80K (Cr) | |
| ₹970.00 | ₹1014.00 | ₹955.10 | ₹993.00 | 35.60K (Cr) | |
| ₹932.10 | ₹972.00 | ₹911.80 | ₹953.55 | 13.20K (Cr) | |
| ₹925.00 | ₹950.00 | ₹925.00 | ₹938.15 | 13.20K (Cr) | |
| ₹953.00 | ₹989.00 | ₹953.00 | ₹986.25 | 5.20K (Cr) | |
| ₹1003.00 | ₹1008.95 | ₹980.30 | ₹991.70 | 9.80K (Cr) | |
| ₹1000.00 | ₹1019.00 | ₹1000.00 | ₹1010.50 | 4.60K (Cr) | |
| ₹1050.05 | ₹1050.05 | ₹1020.30 | ₹1020.30 | 47.00K (Cr) | |
| ₹1170.00 | ₹1190.00 | ₹1156.00 | ₹1156.00 | 12.00K (Cr) |
Anondita Medi — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1042.80 | ₹1100.00 | ₹1042.80 | ₹1097.60 | +5.26% | |
| ₹1000.00 | ₹1050.00 | ₹911.80 | ₹1013.25 | +1.32% | |
| ₹715.80 | ₹1190.00 | ₹715.80 | ₹1020.30 | +42.54% | |
| ₹697.00 | ₹720.00 | ₹634.50 | ₹658.75 | -5.49% | |
| ₹906.00 | ₹906.00 | ₹783.75 | ₹787.65 | -13.06% | |
| ₹992.05 | ₹992.05 | ₹952.85 | ₹952.85 | -3.95% | |
| ₹672.05 | ₹952.80 | ₹672.05 | ₹942.35 | +40.22% | |
| ₹630.00 | ₹675.80 | ₹577.20 | ₹621.80 | -1.30% | |
| ₹420.00 | ₹439.00 | ₹416.05 | ₹434.00 | +3.33% |
AI Research Briefing
Powered by Gemini · 2026-04-13
Overvalued condom play; avoid until growth justifies the hype.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Anondita Medicare's 9% below its 52-week high of On April 10, 2026, the share price was
CORE STORY (THE REAL GAME)
- Strong YoY profit growth
- Growing personal care market in India
- High investor confidence indicated by IPO oversubscription
- Stronger than expected earnings reports
- New international contracts
- Acquisition by a larger player
- Small-cap liquidity risk
- High P/E ratio compared to industry average
- Poor quality and growth metrics
FII: 4.24% (Δ None%) | DII: 6.55% (Δ None%)
The Indian beauty and personal care market is experiencing rapid growth, driven by rising disposable incomes and changing consumer preferences.
Free Cash Flow 5Y: ₹None Cr
In the next 3-6 months, watch for earnings reports to justify the high valuation. A slowdown in growth or failure to secure new contracts could lead to a significant correction.
Primary Thesis Risk
Overvaluation and potential growth deceleration are the biggest threats.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Anondita Medi Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Anondita Medi Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ANONDITA across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Robust Profit Growth (125.61%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (72.24%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Interest Coverage (8.47x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (61.79%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 51.90x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Anondita Medi vs Personal Care Peers
Peer Comparison - Personal Care
Compare Anondita Medi with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Anondita MediAnondita Medi...Selected✓ ANONDITA • | 33.7/100 | ₹1097.60₹1098 | ₹1191.73₹1191.73 | 51.90Average 51.9 Average | — — | — — | 0.43Excellent 0.4 Excellent | — — | — — | 0.00% |
Godrej Consumer Products LtdGodrej Consumer... GODREJCP • 532424 | 42.9/100 | ₹1044.40₹1044 | ₹115504.75₹115504.75 | 61.35Average 61.4 Average | 15.21%Good 15.21% Good | 19.21%Good 19.21% Good | 0.34Excellent 0.3 Excellent | 3.75%Average 3.75% Average | 7.70%Good 7.70% Good | 1.33% |
Dabur India LtdDabur India Ltd... DABUR • 500096 | 45.3/100 | ₹445.45₹445 | ₹91407.05₹91407.05 | 50.53Average 50.5 Average | 17.04%Good 17.04% Good | 20.24%Excellent 20.24% Excellent | 0.12Excellent 0.1 Excellent | 3.01%Average 3.01% Average | 7.66%Good 7.66% Good | 1.55% |
Colgate Palmolive India LtdColgate Palmoli... COLPAL • 500830 | 53.3/100 | ₹2087.40₹2087 | ₹58477.58₹58477.58 | 44.10Average 44.1 Average | 81.19%Excellent 81.19% Excellent | 105.34%Excellent 105.34% Excellent | 0.04Excellent 0.0 Excellent | 11.96%Good 11.96% Good | 5.95%Good 5.95% Good | 2.37% |
Procter & Gamble Hygiene LimitedProcter & Gambl... PGHH • 500459 | 49.3/100 | ₹10115.00₹10115 | ₹41537.66₹41537.66 | 50.25Average 50.3 Average | 75.67%Excellent 75.67% Excellent | 103.79%Excellent 103.79% Excellent | 0.00Excellent 0.0 Excellent | 8.44%Good 8.44% Good | 2.75%Average 2.75% Average | 0.86% |
Gillette India LtdGillette India ... GILLETTE • 507815 | 54.7/100 | ₹8273.50₹8274 | ₹27967.94₹27967.94 | 48.73Average 48.7 Average | 41.62%Excellent 41.62% Excellent | 56.06%Excellent 56.06% Excellent | 0.00Excellent 0.0 Excellent | 10.45%Good 10.45% Good | 3.72%Average 3.72% Average | 1.31% |
Emami LtdEmami Ltd... EMAMILTD • 531162 | 57.2/100 | ₹400.45₹400 | ₹22959.79₹22959.79 | 30.46Average 30.5 Average | 30.18%Excellent 30.18% Excellent | 32.42%Excellent 32.42% Excellent | 0.02Excellent 0.0 Excellent | 21.30%Excellent 21.30% Excellent | 7.49%Good 7.49% Good | 1.52% |
Cupid LtdCupid Ltd... CUPID • 530843 | 32.5/100 | ₹128.90₹129 | ₹9372.27₹9372.27 | 151.83Average 151.8 Average | 12.89%Average 12.89% Average | 17.10%Good 17.10% Good | 0.07Excellent 0.1 Excellent | 0.89%Average 0.89% Average | 2.70%Average 2.70% Average | 0.00% |
Honasa Consumer LtdHonasa Consumer... HONASA • 544014 | 51.3/100 | ₹419.95₹420 | ₹9315.44₹9315.44 | 74.86Average 74.9 Average | 5.51%Poor 5.51% Poor | 7.44%Poor 7.44% Poor | 0.09Excellent 0.1 Excellent | 16.54%Excellent 16.54% Excellent | 76.22%Excellent 76.22% Excellent | 0.00% |
Bajaj Consumer Care LtdBajaj Consumer ... BAJAJCON • 533229 | 58.3/100 | ₹560.75₹561 | ₹3635.38₹3635.38 | 26.63Average 26.6 Average | 15.70%Good 15.70% Good | 19.06%Good 19.06% Good | 0.03Excellent 0.0 Excellent | -7.53%Poor -7.53% Poor | 2.51%Average 2.51% Average | 0.00% |
Radix Industries India LtdRadix Industrie... RADIXIND • 531412 | 57.9/100 | ₹189.95₹190 | ₹268.55₹268.55 | 89.22Average 89.2 Average | 13.21%Average 13.21% Average | 18.76%Good 18.76% Good | 0.01Excellent 0.0 Excellent | 17.19%Excellent 17.19% Excellent | 35.46%Excellent 35.46% Excellent | 0.28% |
Top Personal Care Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Godrej Consumer Products Ltd share price115504.75 Cr
- Dabur India Ltd share price91407.05 Cr
- Colgate Palmolive India Ltd share price58477.58 Cr
- Procter & Gamble Hygiene Limited share price41537.66 Cr
- Gillette India Ltd share price27967.94 Cr
Anondita Medi Quarterly Performance
Latest quarterly metrics for ANONDITA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
72.24%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
125.61%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Anondita Medi Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ANONDITA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Anondita Medi Financial Statements
Annual income statement, balance sheet and cash flow for Anondita Medi (ANONDITA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Anondita Medi
About ANONDITA (Anondita Medi)
Anondita Medi (ANONDITA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Personal Care sector with a current ma...rket capitalisation of ₹1.19K (Cr). The debt-to-equity ratio stands at 0.43, reflecting the company's capital structure. Investors tracking ANONDITA share price can monitor key metrics including P/E ratio, promoter holding of 61.79%, and quarterly earnings growth.
Company Details
ANONDITA Share Price: Frequently Asked Questions
What is the current share price of Anondita Medi?
Anondita Medi (ANONDITA) trades at ₹1097.60 on NSE. Market cap ₹1.19K (Cr). Educational data only.
What is the P/E ratio of Anondita Medi?
Anondita Medi has a P/E of 51.90x vs industry average 50.39x.
What is the Bull Run score for Anondita Medi?
Anondita Medi has a Bull Run score of 33.7/100 based on 25+ financial parameters.
Does Anondita Medi pay dividends?
Anondita Medi has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Anondita Medi?
Anondita Medi has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Anondita Medi?
Anondita Medi has debt-to-equity of 0.43.
Is Anondita Medi a good investment?
Bull Run gives Anondita Medi a score of 33.7/100. This is not investment advice — consult a SEBI-registered advisor.